Testing for Autoimmune Arthritis
Autoimmune joint disease brings recurring inflammation and stiffness. This article covers what mesenchymal stem cell research is studying and how to approach a treatment decision.
- Autoimmune
- 2 min
07/03/2026
Living With Inflamed Joints
Autoimmune joint disease, such as rheumatoid arthritis, causes recurring inflammation, stiffness and a reduced range of motion. Standard treatments remain the foundation of care. Alongside them, regenerative medicine has drawn attention as researchers learn more about the body’s own healing capacity and how it might be supported.
Flares can come and go, which makes planning work and family life harder.
What the Research Examines
Mesenchymal stem cells have been studied across many conditions. In joint disease, researchers want to understand how these cells interact with joint tissue and how they influence the immune processes that drive inflammation. The work is detailed and still evolving, and results so far vary between patients.
Studies measure outcomes such as joint swelling, pain and daily function over months of follow-up.
Care That Fits the Person
People with joint conditions often want care that considers more than symptoms. A useful plan looks at:
- Current symptoms and how they change through the day
- Overall health and other conditions
- Lifestyle, work and activity levels
- Personal preferences and goals
Questions to Bring to Your Doctor
Being informed helps you ask better questions. You might ask what current research shows for your type of arthritis, how a regenerative option would fit with your existing medication and how progress would be measured.
At Regeneration Clinic, a medical evaluation decides whether treatment is appropriate. When it is, we use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords, produced in our in-house laboratory, with check-ins at 1, 3, 6, 9 and 12 months after treatment.
Bringing recent blood tests and imaging to your appointment helps the physician give a clear answer. Results vary between patients, and our team explains what is known and what remains uncertain.
07/03/2026
Related Articles
Frequently asked questions
Read Full FAQAnswers about safety, cost and what to expect.
Our proprietary stem cell standard, refined over 10 years of research and treatment. Sourced from Wharton’s Jelly and produced entirely in-house.
The most common side effect is temporary pain at the injection site. Headache, nausea or fatigue happen rarely and usually resolve within 24 hours. No long-term side effects have been documented to date.
In the US, FDA approval follows a long, costly path for each specific product and condition, and for most conditions mesenchymal stem cell therapy hasn’t completed that path yet. Research continues worldwide, with hundreds of clinical trials underway. Patients travel to Panama for access they can’t get at home, delivered with in-house production, image-guided precision and a team that tells them honestly what to expect.
We treat neurological, autoimmune, orthopedic and sports, cardiovascular and fertility conditions, autism, and support healthy aging. Our medical team reviews every case individually before recommending a protocol.
Yes. Treatment takes place at our clinic in Panama City. Your consultation and case review happen remotely before you book any travel.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance.

Still have a question?
Ask us directly. A patient advocate will reply personally.






